James Shin

Leonid Timashev

Mitchell Kapoor

Yaron Werber

Ashwani Verma

George Farmer

Jessica Fye

Jonathan Miller

Justin Zelin

Kelly Shi

Sean McCutcheon

Vikram Purohit

Gena Wang

Konstantinos Biliouris

Kostas Biliouris

Rick Bienkowski

Dingding Shi

Gena Huidong Wang

Huidong Wang

Jeet Mukherjee

Prem Lachman

Terence Flynn

Umer Raffat

Ziyi Chen

- On **October 6, 2025**, Legend Biotech USA Inc., a wholly-owned subsidiary of Legend Biotech Corporation, entered into a **Component and Product Supply Agreement** with Janssen Pharmaceuticals, Inc.  **[1801198_0001171843-25-006329_f6k_100725.htm:1]** 
- Under this agreement, Legend Biotech will **manufacture and supply** ciltacabtagene autoleucel (cilta-cel) for clinical and commercial use globally, excluding Greater China, from their GMP manufacturing facility in Raritan, New Jersey.  **[1801198_0001171843-25-006329_f6k_100725.htm:1]** 
- Janssen will pay Legend Biotech a transfer price based on total production costs plus a specified markup, with the **costs for commercial and clinical supply ultimately shared equally** by both companies as "Allowable Expenses" and "Development Costs" under their existing Collaboration Agreement.  **[1801198_0001171843-25-006329_f6k_100725.htm:1]** 
- This new agreement **supersedes** the Interim Product Supply Agreement signed by Legend Biotech and Janssen on February 28, 2022.  **[1801198_0001171843-25-006329_f6k_100725.htm:1]**

Legend Biotech USA Enters Supply Agreement with Janssen Pharmaceuticals

Legend Biotech (LEGN)